Spinal Tech

Stryker's stock reached an all-time high on March 30, according to a Stock Caller report.

X-spine Systems, a wholly owned subsidiary of Xtant Medical, received FDA clearance for the Xspan Laminoplasty Fixation System.

Stryker debuted its Stryker Challenge at the PGA Tour's Shell Houston Open in Humble, Texas, according to pharmiweb.com.

Alpharetta, Ga.-based SANUWAVE Health received a U.S. patent called "Increase Electrode Life in Devices Used for Extracorporeal Shockwave Therapy."

InVivo Therapeutics' neuro-spinal scaffold device is designed to reduce paralysis symptoms resulting from acute spinal cord injury, according to MoneyShow.

Belgium-based Bone Therapeutics reported the 12-month efficacy results from the PREOB Phase IIA severe osteoporosis trial.

BioPoly received the CE mark for its BioPoly RS Partial Resurfacing Shoulder System.

Stryker Director Ronda E. Stryker sold 12,000 shares of the company's stock in a recent transaction, according to a South Florida Hedge Fund Managers report.

Amedica shares fell 12.95 percent in short interest, according to Clinton Financial.

During the fourth quarter, Segall Bryant Hamill bought up to 16,097 Orthofix International shares, according to Street Edition.